These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12496043)

  • 1. Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.
    Xu LL; Liu G; Miller DP; Zhou W; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1555-9. PubMed ID: 12496043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point: myeloperoxidase -463G --> a polymorphism and lung cancer risk.
    Feyler A; Voho A; Bouchardy C; Kuokkanen K; Dayer P; Hirvonen A; Benhamou S
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1550-4. PubMed ID: 12496042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A myeloperoxidase polymorphism associated with reduced risk of lung cancer.
    Schabath MB; Spitz MR; Hong WK; Delclos GL; Reynolds WF; Gunn GB; Whitehead LW; Wu X
    Lung Cancer; 2002 Jul; 37(1):35-40. PubMed ID: 12057865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
    Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
    Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population.
    Arslan S; Pinarbasi H; Silig Y
    Mol Med Rep; 2011; 4(1):87-92. PubMed ID: 21461569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.
    Yang WJ; Wang MY; Pan FZ; Shi C; Cen H
    World J Surg Oncol; 2017 Aug; 15(1):144. PubMed ID: 28764808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysis.
    Zhou C; Luo Q; Qing Y; Lin X; Zhan Y; Ouyang M
    Tumour Biol; 2013 Dec; 34(6):3449-55. PubMed ID: 23943394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer.
    Kantarci OH; Lesnick TG; Yang P; Meyer RL; Hebrink DD; McMurray CT; Weinshenker BG
    Mayo Clin Proc; 2002 Jan; 77(1):17-22. PubMed ID: 11794452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population.
    Lu W; Xing D; Qi J; Tan W; Miao X; Lin D
    Int J Cancer; 2002 Nov; 102(3):275-9. PubMed ID: 12397651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.
    Schabath MB; Spitz MR; Delclos GL; Gunn GB; Whitehead LW; Wu X
    Am J Ind Med; 2002 Jul; 42(1):29-37. PubMed ID: 12111688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the myeloperoxidase -463G-->a polymorphism with lung cancer risk.
    Le Marchand L; Seifried A; Lum A; Wilkens LR
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):181-4. PubMed ID: 10698479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible risk reduction in esophageal cancer associated with MPO -463 A allele.
    Matsuo K; Hamajima N; Shinoda M; Hatooka S; Inoue M; Takezaki T; Onda H; Tajima K
    J Epidemiol; 2001 May; 11(3):109-14. PubMed ID: 11434421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the 463G-A myeloperoxidase gene polymorphism with gastric cancer risk.
    Jiang Z; Zhang Z; Wang Z; Zhang G; Hu K; He B; Wang S
    Hepatogastroenterology; 2012 May; 59(115):757-61. PubMed ID: 22094928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
    London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
    Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase G463A polymorphism and risk of lung cancer.
    Li J; Fu Y; Zhao B; Xiao Y; Chen R
    Tumour Biol; 2014 Jan; 35(1):821-9. PubMed ID: 23979979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase genetic polymorphism and lung cancer risk.
    London SJ; Lehman TA; Taylor JA
    Cancer Res; 1997 Nov; 57(22):5001-3. PubMed ID: 9371491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis.
    Taioli E; Benhamou S; Bouchardy C; Cascorbi I; Cajas-Salazar N; Dally H; Fong KM; Larsen JE; Le Marchand L; London SJ; Risch A; Spitz MR; Stucker I; Weinshenker B; Wu X; Yang P
    Genet Med; 2007 Feb; 9(2):67-73. PubMed ID: 17304047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California.
    London SJ; Daly AK; Leathart JB; Navidi WC; Idle JR
    Pharmacogenetics; 1996 Dec; 6(6):527-33. PubMed ID: 9014202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome.
    Hoy A; Leininger-Muller B; Poirier O; Siest G; Gautier M; Elbaz A; Amarenco P; Visvikis S
    Atherosclerosis; 2003 Apr; 167(2):223-30. PubMed ID: 12818404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correspondence re: Feyler et al., Point: Myeloperoxidase (-463)G --> a polymorphism and lung cancer risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554, 2002, and Xu et al., Counterpoint: The myeloperoxidase (-463)G --> a polymorphism does not decrease lung cancer susceptibility in Caucasians. 11: 1555-1559, 2002.
    Dally H; Bartsch H; Risch A
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):683. PubMed ID: 12869414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.